Hearing Disorder
10
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Biospecimen Procurement for Head and Neck Disorders
Genetic Analysis of Hereditary Disorders of Hearing and Balance
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan
Evaluation of Cochlear (Promontory) Stimulation During Awake Ear Surgery (TONES Study)
Impact of Anesthesia Alarm Volume on Mental Workload in Surgical Trainees
Holistic Integration for Healthy Longevity and Aging in Place
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Brain Imaging of Tinnitus